Unknown

Dataset Information

0

Clonal medicine targeting DNA damage response eradicates leukemia.

ABSTRACT:

SUBMITTER: Toma MM 

PROVIDER: S-EPMC10912018 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Targeting PARP proteins in acute leukemia: DNA damage response inhibition and therapeutic strategies.
| S-EPMC8783444 | biostudies-literature
Unknown Macroscopic inhibition of DNA damage repair pathways by targeting AP-2α with LEI110 eradicates hepatocellular carcinoma.
| S-EPMC10951303 | biostudies-literature
Unknown Targeting DNA damage response in cancer therapy.
| S-EPMC4317796 | biostudies-literature
Unknown Targeting the DNA damage response for cancer therapy.
| S-EPMC9988002 | biostudies-literature
Unknown Therapeutic Targeting of DNA Damage Response in Cancer.
| S-EPMC8836062 | biostudies-literature
Unknown Targeting mitochondrial oxidative phosphorylation eradicates therapy-resistant chronic myeloid leukemia stem cells.
| S-EPMC5657469 | biostudies-literature
Unknown Increased clonal hematopoiesis involving DNA damage response genes in patients undergoing lung transplantation.
| S-EPMC10132147 | biostudies-literature
Unknown Targeting DNA Damage Response in Prostate and Breast Cancer.
| S-EPMC7663807 | biostudies-literature
Unknown Targeting USP47 overcomes tyrosine kinase inhibitor resistance and eradicates leukemia stem/progenitor cells in chronic myelogenous leukemia.
| S-EPMC7782553 | biostudies-literature
Unknown Therapeutic targeting of the DNA damage response in prostate cancer.
| S-EPMC8147657 | biostudies-literature